11-119088570-T-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000190.4(HMBS):c.88-65T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.021 in 1,327,078 control chromosomes in the GnomAD database, including 3,792 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.093 ( 2125 hom., cov: 33)
Exomes 𝑓: 0.012 ( 1667 hom. )
Consequence
HMBS
NM_000190.4 intron
NM_000190.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.128
Publications
5 publications found
Genes affected
HMBS (HGNC:4982): (hydroxymethylbilane synthase) This gene encodes a member of the hydroxymethylbilane synthase superfamily. The encoded protein is the third enzyme of the heme biosynthetic pathway and catalyzes the head to tail condensation of four porphobilinogen molecules into the linear hydroxymethylbilane. Mutations in this gene are associated with the autosomal dominant disease acute intermittent porphyria. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Jul 2008]
HMBS Gene-Disease associations (from GenCC):
- acute intermittent porphyriaInheritance: SD, AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BP6
Variant 11-119088570-T-C is Benign according to our data. Variant chr11-119088570-T-C is described in ClinVar as Benign. ClinVar VariationId is 1246134.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.311 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0927 AC: 14099AN: 152068Hom.: 2105 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
14099
AN:
152068
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0117 AC: 13713AN: 1174892Hom.: 1667 AF XY: 0.0102 AC XY: 6111AN XY: 598352 show subpopulations
GnomAD4 exome
AF:
AC:
13713
AN:
1174892
Hom.:
AF XY:
AC XY:
6111
AN XY:
598352
show subpopulations
African (AFR)
AF:
AC:
9238
AN:
27596
American (AMR)
AF:
AC:
1012
AN:
44288
Ashkenazi Jewish (ASJ)
AF:
AC:
59
AN:
24414
East Asian (EAS)
AF:
AC:
0
AN:
38474
South Asian (SAS)
AF:
AC:
65
AN:
80772
European-Finnish (FIN)
AF:
AC:
34
AN:
53318
Middle Eastern (MID)
AF:
AC:
157
AN:
5080
European-Non Finnish (NFE)
AF:
AC:
1805
AN:
850218
Other (OTH)
AF:
AC:
1343
AN:
50732
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
576
1152
1727
2303
2879
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
254
508
762
1016
1270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0930 AC: 14160AN: 152186Hom.: 2125 Cov.: 33 AF XY: 0.0903 AC XY: 6720AN XY: 74432 show subpopulations
GnomAD4 genome
AF:
AC:
14160
AN:
152186
Hom.:
Cov.:
33
AF XY:
AC XY:
6720
AN XY:
74432
show subpopulations
African (AFR)
AF:
AC:
13081
AN:
41472
American (AMR)
AF:
AC:
710
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
AC:
5
AN:
3472
East Asian (EAS)
AF:
AC:
0
AN:
5176
South Asian (SAS)
AF:
AC:
6
AN:
4824
European-Finnish (FIN)
AF:
AC:
8
AN:
10616
Middle Eastern (MID)
AF:
AC:
9
AN:
294
European-Non Finnish (NFE)
AF:
AC:
196
AN:
68014
Other (OTH)
AF:
AC:
145
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
503
1006
1509
2012
2515
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
122
244
366
488
610
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
103
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jun 21, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.